Coordinate transcriptional regulation of transport and metabolism

被引:53
作者
Eloranta, JJ [1 ]
Meier, PJ
Kullak-Ublick, GA
机构
[1] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Internal Med, Div Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland
来源
PHASE II CONJUGATION ENZYMES AND TRANSPORT SYSTEMS | 2005年 / 400卷
关键词
D O I
10.1016/S0076-6879(05)00028-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Intestinal absorption and hepatic clearance of drugs, xenobiotics, and bile acids are mediated by transporter proteins expressed at the plasma membranes of intestinal epithelial cells and liver parenchymal cells in a polarized manner. Within enterocytes and hepatocytes, these exogenous or endogenous, potentially toxic compounds may be metabolized by phase I cytochrome P450 (CYP) and phase 11 conjugating enzymes. Many transporter proteins and metabolizing enzymes are subject to direct translational modification, enabling very rapid changes in their activity. However, to achieve intermediate and longer term changes in transport and enzyme activities, the genes encoding drug and bile acid transporters, as well as the CYP and conjugating enzymes, are regulated by a complex network of transcriptional cascades. These are typically mediated by specific members of the nuclear receptor family of transcription factors, particularly FXR, SHP, PXR, CAR, and HNF-4 alpha. Most nuclear receptors are activated by specific ligands, including numerous xenobiotics (PXR, CAR) and bile acids (FXR). The fine-tuning of transcriptional control of drug and bile acid homeostasis depends on regulated interactions of specific nuclear receptors with their target genes.
引用
收藏
页码:511 / +
页数:21
相关论文
共 102 条
[1]   Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor [J].
Ananthanarayanan, M ;
Balasubramanian, N ;
Makishima, M ;
Mangelsdorf, DJ ;
Suchy, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :28857-28865
[2]   Neither intestinal sequestration of bile acids nor common bile duct ligation modulate the expression and function of the rat ileal bile acid transporter [J].
Arrese, M ;
Trauner, M ;
Sacchiero, RJ ;
Crossman, MW ;
Shneider, BL .
HEPATOLOGY, 1998, 28 (04) :1081-1087
[3]   Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice [J].
Assem, M ;
Schuetz, EG ;
Leggas, M ;
Sun, DX ;
Yasuda, K ;
Reid, G ;
Zelcer, N ;
Adachi, M ;
Strom, S ;
Evans, RM ;
Moore, DD ;
Borst, P ;
Schuetz, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) :22250-22257
[4]   Repression of CAR-mediated transactivation of CYP2B genes by the orphan nuclear receptor, short heterodimer partner (SHP) [J].
Bae, YJ ;
Kemper, JK ;
Kemper, B .
DNA AND CELL BIOLOGY, 2004, 23 (02) :81-91
[5]   FXR induces the UGT2B4 enzyme in hepatocytes: A potential mechanism of negative feedback control of FXR activity [J].
Barbier, O ;
Torra, IP ;
Sirvent, A ;
Claudel, T ;
Blanquart, C ;
Duran-Sandoval, D ;
Kuipers, F ;
Kosykh, V ;
Fruchart, JC ;
Staels, B .
GASTROENTEROLOGY, 2003, 124 (07) :1926-1940
[6]   Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction [J].
Bertilsson, G ;
Heidrich, J ;
Svensson, K ;
Åsman, M ;
Jendeberg, L ;
Sydow-Bäckman, M ;
Ohlsson, R ;
Postlind, H ;
Blomquist, P ;
Berkenstam, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12208-12213
[7]   Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1α -: Functional implications in hepatic cholesterol and glucose metabolism [J].
Bhalla, S ;
Ozalp, C ;
Fang, SS ;
Xiang, LJ ;
Kemper, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (43) :45139-45147
[8]   SXR, a novel steroid and xenobiotic-sensing nuclear receptor [J].
Blumberg, B ;
Sabbagh, W ;
Juguilon, H ;
Bolado, J ;
van Meter, CM ;
Ono, ES ;
Evans, RM .
GENES & DEVELOPMENT, 1998, 12 (20) :3195-3205
[9]   Orphan nuclear receptors - new ligands and new possibilities [J].
Blumberg, B ;
Evans, RM .
GENES & DEVELOPMENT, 1998, 12 (20) :3149-3155
[10]   Liver-enriched transcription factors and hepatocyte differentiation [J].
Cereghini, S .
FASEB JOURNAL, 1996, 10 (02) :267-282